GSOR02   Presentation Time: 12:05 PM

Brachytherapy (BT) target dose and coverage are critical to the cure of locally advanced cervical cancer (CC). Advances in imaging, volumetric definitions, and BT planning aims/constraints have collectively been associated with improved tumor control outcomes over traditional practices. But some historic conventions remain in BT, such as applying uniform radiobiological parameters (RbP). Having previously generated a/b and T1/2 from CC cell lines, we explored the potential impact of differing RbP against population-based outcomes in an era of MR-BT boost.

Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Authors: Fleur Huang, Sunita Ghosh, Shyam Menon, Braden Chow, Julie Cuartero, Armin Gamper, Brad Warkentin, Ericka Wiebe, Corinne Doll, Geetha Menon Source Type: research